Daily News Podcast

Bempedoic acid: funny name, serious LDL lowering

Publish date: March 15, 2019

 

Bempedoic acid safely dropped LDL cholesterol, and now it’s up for FDA approval. Recent trials advance axial spondyloarthritis therapy. Newer antihyperglycemic drugs have distinctive cardiovascular, kidney benefits. And doctors’ prior authorization burden is increasing.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Cancer-battling breath, Zombie Bambi, and hops as health food
MDedge Dermatology
Recurrence of Elevated Intracranial Pressure Following Tetracycline Antibiotic Use
MDedge Dermatology
Risk for Appendicitis, Cholecystitis, or Diverticulitis in Patients With Psoriasis
MDedge Dermatology
Patients who want to make you retire, and how to cope
MDedge Dermatology
Erythematous Edematous Plaques on the Dorsal Aspects of the Hands
MDedge Dermatology
Esketamine gets the green light for depression
MDedge Dermatology
Ready for universal hepatitis C testing?
MDedge Dermatology
Autism risk with in utero infections
MDedge Dermatology
Aspirin and lower risk of COPD flare-up
MDedge Dermatology
Semaglutide plus SGLT2 inhibitors for type 2 diabetes
MDedge Dermatology